241
Participants
Start Date
February 8, 2024
Primary Completion Date
September 6, 2024
Study Completion Date
September 6, 2024
Cannabidiol
Cannabidiol (Epidiolex) will be administered orally 2.5 mg/kg twice daily (5 mg/kg/day) for 28 days in Part 1 and for 9 days (morphine cohort) or 12 days (citalopram cohort) in Part 2.
Placebo
Placebo will be administered orally twice daily for 28 days in Part 1
Citalopram
Citalopram (Celexa) will be administered once at 20 mg on days 1 and 13.
Morphine
Morphine will be administered once at 15 mg on days 1, 4, and 11.
Spaulding Clinical Research, West Bend
Spaulding Clinical Research LLC
OTHER
Food and Drug Administration (FDA)
FED